Page 102 - Demo

ANALESRANFwww.analesranf.comet al. The bacterial curli system possesses a potent andselective inhibitor of amyloid formation. Mol Cell.2015;57:445-55.51. Chen SG, Stribinskis v, Rane MJ, Demuth DR, Gozal E,Roberts AM, et al. Exposure to the functional bacterialamyloid protein curli enhances alpha-synucleinaggregation in aged Fischer 344 rats andCaenorhabditis elegans. Sci Rep. 2016;6:34477.52. wang C, Lau Cy, Ma F, Zheng C. Genome-wide screenidentifies curli amyloid fibril as a bacterial componentpromoting host neurodegeneration. Proc Natl Acad SciUSA. 2021;118:e2106504118.53. Goya ME, Xue F, Sampedro-Torres-Quevedo C, ArnaouteliS, Riquelme-Dominguez L, Romanowski A, et al.Probiotic bacillus subtilis protects against alphasynuclein aggregation in C. elegans. Cell Rep.2020;30:367%u201380.54. Sampson TR, Challis C, Jain N, Moiseyenko A, LadinskyMS, Shastri GG, et al. A gut bacterial amyloid promotesalpha-synuclein aggregation and motor impairment inmice. eLife. 2020;9:e53111.55. Meng L, Liu C, Li y, Chen G, Xiong M, yu T, et al. The yeastprion protein Sup35 initiates %u03b1-synuclein pathology inmouse models of Parkinson%u2019s disease. Sci Adv.2023;9:eadj1092.56. Schmit KJ, Garcia P, Sciortino A, Aho vTE, Pardo-Rodriguezb, Thomas MH, et al. Fiber deprivation andmicrobiome-borne curli shift gut bacterial populationsand accelerate disease in a mouse model ofParkinson%u2019s disease. Cell Rep. 2023;42:113071.57. Iglesias v, de Groot NS, ventura S. Computational analysisof candidate prion-like proteins in bacteria and theirrole. Front Microbiol. 2015;6:1123.58. Seira Curto J, Dominguez Martinez A, Sotillo Sotillo P,Serrat Garcia M, Fernandez MR, Sanchez de Groot N.Microbiome-derived prion-like proteins and theirpotential to trigger cognitive dysfunction. bioRxiv.2023;doi:10.1101/2023.10.19.563052.59. vendrell-Fern%u00e1ndez S, Lozano-Picazo P, Cuadros-S%u00e1nchezP, Tejero-Ojeda MM, Giraldo R. Conversion of the OmpFporin into a device to gather amyloids on the E. coliouter membrane. ACS Synth biol. 2022;11:655-67.60. Taleb NN. El cisne negro: El impacto de lo altamenteimprobable. Ed. Paid%u00f3s Ib%u00e9rica. 2011; ISbN:9788449326622.61. Giraldo R, Fern%u00e1ndez-Tresguerres ME. Twenty years of thepPS10 replicon: Insights on the molecular mechanismfor the activation of DNA replication in iteroncontaining bacterial plasmids. Plasmid. 2004;52:69-83.62. Gasset-Rosa F, D%u00edaz-L%u00f3pez T, Lurz R, Prieto A, Fern%u00e1ndezTresguerres ME, Giraldo R. Negative regulation ofpPS10 plasmid replication: Origin pairing by zippingup DNA-bound RepA monomers. Mol Microbiol.2008;68:560-72.63. Giraldo R, Fern%u00e1ndez-Tornero C, Evans PR, D%u00edaz-Orejas R,Romero A. A conformational switch betweentranscriptional repression and replication initiation inthe RepA dimerization domain. Nat Struct biol.2003;10:565%u201371.64. D%u00edaz-L%u00f3pez T, Lages-Gonzalo M, Serrano-L%u00f3pez A, AlfonsoC, Rivas G, D%u00edaz-Orejas R, et al. Structural changes in31. Grabrucker S, Marizzoni M, Silajd%u017ei c E, Lopizzo N,Mombelli E, Nicolas S, et al. Microbiota fromAlzheimer%u2019s patients induce deficits in cognition andhippocampal neurogenesis. brain. 2023; 1-19.32. blacher E, bashiardes S, Shapiro H, Rothschild D, Mor U,Dori-bachash M, et al. Potential roles of gutmicrobiome and metabolites in modulating ALS inmice. Nature. 2019:572:474%u201380.33. Zmora N, Zilberman-Schapira G, Suez J, Mor U, Doribachash M, bashiardes S, et al. Personalized gutmucosal colonization resistance to empiric probioticsis associated with unique host and microbiomefeatures. Cell. 2018;174:1368%u2013405.34. Suez J, Elinav E. The path towards microbiome-basedmetabolite treatment. Nat Microbiol. 2017;2:17075.35. Iadanza MG, Jackson MP, Hewitt Ew, Ranson NA, RadfordSE. A new era for understanding amyloid structures anddisease. Nat Rev Mol Cell biol. 2018;19:755%u201373.36. walker LC, Jucker M. Propagation and spread ofpathogenic protein assemblies in neurodegenerativediseases. Nat Neurosci. 2018;21:1341%u20139.37. Sawaya MR, Hughes MP, Rodriguez JA, Riek R, EisenbergDS. The expanding amyloid family: Structure, stability,function, and pathogenesis. Cell. 2021;184:4857%u201373.38. Pinheiro F, Santos J, ventura S. AlphaFold and the amyloidlandscape. J Mol biol. 2021;433:167059.39. Ragonis-bachar P, Axel G, blau S, ben-Tal N, Kolodny R,Landau M. what can AlphaFold do for antimicrobialamyloids? Proteins. 2024;92:265-81.40. Louros N, Schymkowitz J, Rousseau F. Mechanisms andpathology of protein misfolding and aggregation. NatRev Mol Cell biol. 2023;24:912-33.41. Scheckel C, Aguzzi A. Prions, prionoids and proteinmisfolding disorders. Nat Rev Genet. 2018;19:405%u201318.42. Taglialegna A, Lasa I, valle J. Amyloid structures as biofilmmatrix scaffolds. J bacteriol. 2016;198:2579-88.43. van Gerven N, van der verren SE, Reiter DM, Remaut H.The role of functional amyloids in bacterial virulence.J Mol biol. 2018;430:3657%u20138444. Chapman MR, Robinson LS, Pinkner JS, Roth R, Heuser J,Hammar M, et al. Role of Escherichia coli curli operonsin directing amyloid fiber formation. Science.2002;295:851-5.45. Deshmukh M, Evans ML, Chapman MR. Amyloid by design:Intrinsic regulation of microbial amyloid assembly. JMol biol. 2018;430:3631%u201341.46. Dueholm MS, Petersen Sv, S%u00f8nderk%u00e6r M, Larsen P,Christiansen G, Hein KL, et al. Functional amyloid inPseudomonas. Mol Microbiol. 2010;77:1009-20.47. Taglialegna A, Navarro S, ventura S, Garnett JA, MatthewsS, Penades JR, et al. Staphylococcal bap proteins buildamyloid scaffold biofilm matrices in response toenvironmental signals. PLoS Pathog.2016;12:e1005711.48. El Mammeri N, Hierrezuelo J, Tolchard J, C%u00e1mara-Almir%u00f3nJ, Caro-Astorga J, %u00c1lvarez-Mena A, et al. Moleculararchitecture of bacterial amyloids in bacillus biofilms.FASEb J. 2019;33:12146%u201363.49. Rayan b, barnea E, Khokhlov A, Upcher A, Landau M.Differential fibril morphologies and thermostabilitydetermine functional roles of Staphylococcus aureusPSM%u03b11 and PSM%u03b13. Front Mol biosci. 2023;10:1184785.50. Evans ML, Chorell E, Taylor JD, %u00c5den J, G%u00f6theson A, Li F,De la microbiota como %u201ccisne negro%u201d: El extra%u00f1o caso de losamiloides bacterianos y la neurodegeneraci%u00f3nRafael Giraldo Su%u00e1rez95 An. R.Acad. Farm.Vol. 90. n%u00ba 1 (2024) %u00b7 pp. 83-96